Why TG-rich lipoproteins-non-HDL-Cholesterol matter when assessing CVD risk? – Introduction
Kausik Ray
85th EAS Congress 2017
Why TG-rich lipoproteins-non-HDL-Cholesterol matter when assessing CVD risk? – DiscussionFaculty Presenter(s)
85th EAS Congress 2017
Using naturally randomized genetic evidence to understand heritability of coronary artery disease?Brian Ference
85th EAS Congress 2017
Updates on the guidelines. Which role for nutraceuticals?Emilio Ros
85th EAS Congress 2017
Typical clinical cases – who may benefit?Eric Bruckert
85th EAS Congress 2017
The value of generic medicinesGianni Corrao
85th EAS Congress 2017
The new EAS-ESC Guidelines on diet and lifestyle in cardiovascular preventionGabriele Riccardi
85th EAS Congress 2017
The clinical evidence – Meta-analysis of the RCTMatteo Pirro
85th EAS Congress 2017
The case for immune cells – An expanded cardiovascular continuumPeter Libby
85th EAS Congress 2017
Temporal versus one-time biomarker measurementsLars Lind
85th EAS Congress 2017